Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
  Division of Sexually Transmitted Diseases
    Program and Training Branch
STD Prevention STD Training Home Links Contact Us Glossary 
Skip Navigation Links
Self-Study Modules
Vaginitis
Course Objective
Line separator
Target audience
Line separator
Continuing education
Lessons
Line separator
Introduction
Line separator
Diagnosis and Evaluation
Line separator
Trichomoniasis
Line separator
Candidiasis
Line separator
Bacterial Vaginosis (BV)
Line separator
Case study
Line separator
Resources
Line separator
Self-Study STD Module - Vaginitis

Resources

Publications

  1. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey Data. Obstet Gynecol. 2007 Jan; 109(1):114-20.
  2. American Social Health Association. Sexually transmitted diseases in America: How many cases and at what cost? Menlo Park (CA): Kaiser Family Foundation; 1998. Available from URL: http://www.kff.org/womenshealth/1445-std_rep.cfm .
  3. Berger BJ, et al. Bacterial vaginosis in lesbians: a sexually transmitted disease. Clin Infect Dis 1995; 21:1402-5.
  4. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Obstet Gynecol 1995; 172:525–9.
  5. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 2000; 342:534–40.
  6. CDC. Sexually transmitted diseases treatment guidelines 2006. MMWR 2006; 55 (No. RR-11). Available from URL: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5511a1.htm .
  7. Hauth JC, et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. New Engl J Med 1995; 333:1732-1736.
  8. Hay P, Ugwumadu AHN, Manyonda IT. Oral clindamycin prevents spontaneous preterm birth and mid trimester miscarriage in pregnant women with bacterial vaginosis. Int J STD AIDS 2001;12 (Suppl 2):70-1.
  9. Hillier SL, et al. Association between bacterial vaginosis and pre-term delivery of a low-birth weight infant. New Engl J Med 1995; 333:1737-1742.
  10. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487–93.
  11. Krieger JN. Trichomoniasis in men: old issues and new data. Sex Transm Dis 1995; 22:83-96.
  12. Larsson P-G, et al. Incidence of pelvic inflammatory disease after first trimester legal abortion with bacterial vaginosis after treatment with metronidazole: a double-blind randomized study. Am J Obstet Gynecol 1992; 166:100-103.
  13. Miller WC, Swygard H, Hobbs MM, et al. The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis 2005; 32:593-8.
  14. Schwebke JR, Desmond R. Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases. Sex Transm Dis 2005; 32(11):654-8.
  15. Sewankambo N, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350:546-550.
  16. Skinner CJ. A case-controlled study of the sexual needs of lesbians. Genitourin Med 1996; 72:277-280.
  17. Sobel J, Peipert JF, McGregor JA, et al. Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis. Infect Dis Obstet Gynecol 2001; 9:9–15.
  18. Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006;194:1283–9.
  19. U.S. Preventive Services Task Force. Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008 Feb 5; 148(3):214-9.
  20. Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis 2005; 192:2039-44.
  21. Wasserheit JN. Epidemiologic synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19:61-77.
  22. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Repro Hlth 2004; 36 (1): 6-10.
  23. Wendel KA, Workowski KA. Trichomoniasis: Challenges to Appropriate Management. Clin Infect Dis 2007; 44 (Suppl 3):S123-9.

Websites and Other Resources

  1. CDC Division of STD Prevention: www.cdc.gov/std
  2. National Network of STD/HIV Prevention Training Centers: http://nnptc.org/
  3. 2006 CDC STD Treatment Guidelines (including downloadable version for Palm devices): http://www.cdc.gov/STD/treatment/
  4. STD information and referrals to STD clinics:
    CDC INFO
    1-800-CDC-INFO (800-232-4636)
    TTY: 1-888-232-6348
    In English, en Español
  5. CDC National Prevention Information Network (NPIN): www.cdcnpin.org
  6. American Social Health Association (ASHA): www.ashastd.org
Page 25 of 26 BackStatusStatusNext


STD Home
| STD Index

CDC Home | Search | Health Topics A-Z

Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
     Division of Sexually Transmitted Diseases Prevention